Aoxing Receives Manufacturing License for Joint Venture With Macfarlan Smith

Aoxing Pharmaceutical Monday announced the China State Food and Drug Administration granted a Manufacturing License to Hebei Aoxing API Pharmaceutical Company, Ltd., the joint venture between Aoxing Pharma and Macfarlan Smith Ltd, a wholly owned subsidiary of Johnson Matthey Plc.
Stockwatch